912 reports of this reaction
1.5% of all CAFFEINE CITRATE reports
#2 most reported adverse reaction
PERICARDITIS is the #2 most commonly reported adverse reaction for CAFFEINE CITRATE, manufactured by Hikma Pharmaceuticals USA Inc.. There are 912 FDA adverse event reports linking CAFFEINE CITRATE to PERICARDITIS. This represents approximately 1.5% of all 60,859 adverse event reports for this drug.
Patients taking CAFFEINE CITRATE who experience pericarditis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PERICARDITIS is a less commonly reported adverse event for CAFFEINE CITRATE, but still significant enough to appear in the safety profile.
In addition to pericarditis, the following adverse reactions have been reported for CAFFEINE CITRATE:
The following drugs have also been linked to pericarditis in FDA adverse event reports:
PERICARDITIS has been reported as an adverse event in 912 FDA reports for CAFFEINE CITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PERICARDITIS accounts for approximately 1.5% of all adverse event reports for CAFFEINE CITRATE, making it one of the most commonly reported side effect.
If you experience pericarditis while taking CAFFEINE CITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.